Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1577 of 6351
-
Hepatitis b breakthrough? new drug AHB-137 shows promise in Long-Term Follow-Up
Disease control Recruiting nowThis study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Aspirin may shield cancer patients from deadly clots during chemo
Prevention Recruiting nowThe purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based chemotherapy and low-dose acetylsalicylic acid (ASA) and compare to relevant hi…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Second dose of experimental drug may help heart amyloidosis patients
Disease control OngoingThis is a Phase 2, single-arm, multicenter study to evaluate the pharmacodynamics and safety of re-treatment with ALXN2220 in previous participants of Study NI006-101.
Phase 2 • Sponsor: Neurimmune AG • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can two cancer pills keep breast cancer from returning?
Disease control Recruiting nowTo evaluate the efficacy and safety of adjuvant CDK4/6 inhibitors in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
Sponsor: Wenjin Yin • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug targets rare gene fault in advanced cancers
Disease control Recruiting nowThe goal of this clinical study is to learn more about the study drug, GS-5319, its dosing, safety and tolerability when given as a single medication and as a combined medication in adults with solid tumors, where the participants show a specific gene alteration in the tumor. The…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New study combines HIV prevention and opioid care at local pharmacies
Prevention Recruiting nowThe purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, …
Phase 4 • Sponsor: Cara Spence • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Scientists hunt for molecular proof that music helps Alzheimer's patients
Knowledge-focused CompletedThe purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive meth…
Sponsor: University of Central Florida • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
New pill hopes to tackle tough lymphoma
Disease control Recruiting nowThis is a Phase I Clinical Study to Evaluate the Safety, Efficacy, and PK/PD Characteristics of HSK47977 Tablets in Subjects with Relapsed or Refractory Non-Hodgkin's Lymphoma.This study includes a Phase Ia dose-escalation stage and a Phase Ib dose-expansion stage, and it is expe…
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Brain scan breakthrough: new MRI spots tumor vs. radiation scar
Diagnosis Recruiting nowThis clinical trial studies whether advanced magnetic resonance imaging (MRI) techniques, including diffusion-relaxation correlation spectrum imaging (DR-CSI) and sodium imaging, can be used to identify the difference between brain tumors that come back after a period of improvem…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New siRNA drug aims to tame kidney disease
Disease control Recruiting nowThis Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated kidney diseases.
Phase 2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for advanced breast cancer: real-world trial of targeted drug begins
Disease control Recruiting nowTo evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.
Sponsor: Wenjin Yin • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Real-World study tracks Ribociclib's impact on early breast cancer
Disease control Recruiting nowThis is a non-interventional, prospective, single-arm, observational study describing the real-world effectiveness, safety, and PRO and HCRU data of ribociclib combined with adjuvant ET under conditions of routine clinical practice in HR+/HER2- EBC in premenopausal, perimenopausa…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene test could make chemo safer by tailoring doses
Disease control Recruiting nowTo prospectively evaluate the efficacy and safety of DPYD-guided dosing strategies in a real-world clinical setting, specifically by comparing the incidence of severe (Grade 3 and 4) fluoropyrimidine-related toxicities of heterozygous DPYD variant patients assigned to DPYD-guided…
Phase 4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for brain fog in schizophrenia? drug trial targets memory and focus
Symptom relief Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose regiments of KYN-5356 and placebo for 28 days. Participants will be randomized to one of 4 treatment …
Phase 2 • Sponsor: Kynexis B.V. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. The main questions if aims to answer are: * Does CP-383 slow or stop the growth of cancer in patients with advanced cancer…
Phase 1/2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for advanced cancer? first human trial of BNT3212 begins
Disease control Recruiting nowThe aim of this first-in-human (FIH) open-label, multi-site study is to evaluate safety, tolerability, pharmacokinetics (PK), immunogenicity and preliminary clinical efficacy of BNT3212, including identification of the recommended dose of BNT3212 for use as monotherapy and with p…
Phase 1/2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New therapy could beat CBT for anxiety – but is it too early to tell?
Symptom relief Recruiting nowBackground Anxiety disorders are the most prevalent psychiatric disorders around the world. Effective treatment consists of pharmacotherapy or psychological treatment based on cognitive-behavioral therapy (CBT) and these treatment options are recommended in clinical guidelines,…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Acupuncture meets brain zaps: new combo aims to restore movement after stroke
Symptom relief Recruiting nowThis study aims to evaluate the combined efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and Electroacupuncture (EA) in improving motor function recovery post-stroke, compared to rTMS combined with sham EA. Participants will receive either active EA or sham EA alo…
Sponsor: Jing Tao • Aim: Symptom relief
Last updated Jun 26, 2026 13:48 UTC
-
New drug litfulo tracked in 3,000 patients for hair loss treatment
Disease control Recruiting nowThe purpose of this observation study is to learn about the safety and effects of the study medicine (called Litfulo) for the potential treatment of Severe Alopecia Areata.
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for frail seniors with head and neck cancer: easier treatment regimen tested
Disease control Recruiting nowThis is a study conducted in patients with a diagnosis of stage IB-IVA squamous cell carcinoma of the head and neck. Patients will have a comprehensive geriatric assessment (CGA) as part of standard assessments. The patients classified as frail, with a CGA score of 3-5, will then…
Phase 3 • Sponsor: Brown University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC